[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Procter & Gamble Company (PG). The filer notifies intent to sell 11,198 shares of Common Stock through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 08/19/2025. The aggregate market value of the proposed sale is reported as $1,734,626.19 and the issuer's shares outstanding are shown as 2,342,371,488. The securities were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the filer lists acquiring 18,834 shares and indicates payment on 08/18/2025. No sales in the past three months are reported. The notice includes the standard representation about lack of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for a small block of PG common stock; immaterial relative to shares outstanding.

The filing reports a proposed sale of 11,198 shares of PG acquired the prior day under a company performance stock program, to be executed through Morgan Stanley Smith Barney on the NYSE. The aggregate value reported is $1.73 million against 2.34 billion shares outstanding, indicating the transaction is immaterial to market capitalization. The form discloses no prior sales in the last three months and includes the required certification about material nonpublic information.

Corporate Governance Expert

TL;DR: Filing appears procedurally complete for a Rule 144 sale tied to a performance award; no governance red flags disclosed.

The notice identifies a sale tied to a Performance Stock Program Award and lists broker and timing details, fulfilling Rule 144 disclosure elements. The filer certifies absence of undisclosed material adverse information. The document does not name the selling individual or provide additional governance context, and it reports no recent sales within three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	11198	1734626.19	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			18834	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for PG disclose about the proposed sale?

The form discloses a proposed sale of 11,198 shares of PG common stock via Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/19/2025 and aggregate value of $1,734,626.19.

When and how were the shares being sold acquired according to the filing?

The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company, with an indicated acquired amount of 18,834 shares and payment dated 08/18/2025.

Does the Form 144 report any sales of PG shares in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What broker and exchange are named for the proposed sale in the filing?

The broker listed is Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza) and the exchange named is the NYSE.

How large is the proposed sale relative to shares outstanding per the filing?

The filing shows 11,198 shares to be sold versus 2,342,371,488 shares outstanding, indicating the block is a very small fraction of the outstanding shares.